[Pathogenesis and progression of neuropathies in diabetic patients with endothelial dysfunction]

Nihon Rinsho. 2005 Jun:63 Suppl 6:516-20.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Aldehyde Reductase / antagonists & inhibitors
  • Animals
  • Antioxidants / therapeutic use
  • C-Peptide / therapeutic use
  • Diabetes Mellitus / physiopathology*
  • Diabetic Neuropathies / drug therapy
  • Diabetic Neuropathies / etiology*
  • Disease Progression
  • Drug Design
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / physiopathology*
  • Humans
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / physiology
  • Nitric Oxide Synthase Type III
  • Peripheral Nerves / blood supply
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology
  • Protein Kinase C beta
  • Thioctic Acid / therapeutic use
  • Vasodilation

Substances

  • Antioxidants
  • C-Peptide
  • Nitric Oxide
  • Thioctic Acid
  • Aldehyde Reductase
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Protein Kinase C
  • Protein Kinase C beta